scholarly article | Q13442814 |
P2093 | author name string | Hahn H | |
Maurer B | |||
Rethwilm A | |||
Kranz M | |||
Baunach G | |||
P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 | ||
A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
Importance of the nef gene for maintenance of high virus loads and for development of AIDS | Q29618369 | ||
Human immunodeficiency virus type 1 negative factor is a transcriptional silencer | Q33836630 | ||
Identification of HIV-1 vpr product and function | Q34168026 | ||
Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. | Q34323971 | ||
Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor | Q34323995 | ||
The biochemistry of AIDS. | Q34843720 | ||
5'-3' exonucleases in phosphorothioate-based oligonucleotide-directed mutagenesis | Q35943171 | ||
Spumaviruses: a group of complex retroviruses | Q36405387 | ||
Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression | Q36687102 | ||
Characterization of the transcriptional trans activator of human foamy retrovirus | Q36689048 | ||
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. | Q36770468 | ||
Regulation of human immunodeficiency virus replication | Q36784581 | ||
The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region | Q37389337 | ||
Human immunodeficiency virus as a prototypic complex retrovirus. | Q37644114 | ||
Regulation of expression of human immunodeficiency virus | Q37783139 | ||
Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus. | Q38320613 | ||
Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants. | Q40043461 | ||
Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures | Q40058961 | ||
Functional organization of the Bel-1 trans activator of human foamy virus | Q40061319 | ||
Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays. | Q40199328 | ||
Infectious DNA of the Human spumaretrovirus | Q40514129 | ||
Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes | Q41345466 | ||
Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of thebel 1 gene | Q41668478 | ||
Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice | Q42013986 | ||
Identification of pol-related gene products of human foamy virus | Q42616568 | ||
Identification of the major immunogenic structural proteins of human foamy virus | Q43758921 | ||
Characterization of a foamy virus isolated fromCercopithecus aethiops lymphoblastoid cells | Q45804708 | ||
An unusual virus in cultures from a human nasopharyngeal carcinoma | Q45821362 | ||
Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR | Q68097623 | ||
Molecular cloning of the genome of human spumaretrovirus | Q69819043 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5411-5418 | |
P577 | publication date | 1993-09-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Functional analysis of human foamy virus accessory reading frames | |
P478 | volume | 67 |
Q38394187 | APOBECs and virus restriction |
Q40416439 | Analysis and function of prototype foamy virus envelope N glycosylation |
Q39881327 | Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle |
Q39579229 | Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors |
Q39578506 | Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing |
Q40436028 | Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity |
Q33782187 | Characterization of provirus clones of simian foamy virus type 1. |
Q38315226 | Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env. |
Q35891703 | Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses |
Q39590160 | Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging |
Q40182244 | Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome |
Q42446353 | Deletion analysis of both the long terminal repeat and the internal promoters of the human foamy virus |
Q26852372 | Evolution of foamy viruses: the most ancient of all retroviruses |
Q40419693 | Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors |
Q38121801 | Feline foamy virus-based vectors: advantages of an authentic animal model |
Q26864134 | Foamy virus biology and its application for vector development |
Q39549687 | Foamy virus capsids require the cognate envelope protein for particle export |
Q40589945 | Foamy virus integration |
Q24629599 | Foamy virus nuclear RNA export is distinct from that of other retroviruses |
Q39642443 | Foamy virus particle formation |
Q40599122 | Foamy virus--adenovirus hybrid vectors. |
Q33652656 | Foamy viruses are unconventional retroviruses |
Q41384741 | Functional analysis of human spuma retrovirus genome |
Q40746225 | Gene transfer with foamy virus vectors |
Q34441425 | Helper-free foamy virus vectors |
Q40835749 | Human foamy virus Bel 1 transactivator/estrogen receptor fusion proteins allow inducible transactivation of both human foamy virus promoters |
Q28249872 | Human foamy virus reverse transcription that occurs late in the viral replication cycle |
Q35116812 | Identification and functional characterization of Bet protein as a negative regulator of BFV3026 replication |
Q39577290 | Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter. |
Q35859826 | In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus |
Q39683121 | Intra- and intercellular trafficking of the foamy virus auxiliary bet protein |
Q36567350 | MicroRNAs: expression, avoidance and subversion by vertebrate viruses |
Q37743255 | Molecular biology of foamy viruses |
Q40038468 | Nuclear localization of foamy virus Gag precursor protein. |
Q27026209 | Nuclear trafficking of retroviral RNAs and Gag proteins during late steps of replication |
Q33823808 | Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene. |
Q39873526 | Productive persistent infection of hematopoietic cells by human foamy virus |
Q37683479 | Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity |
Q40467605 | Regulation of Foamy Virus Gene Expression |
Q39953373 | Subviral particle release determinants of prototype foamy virus |
Q39874739 | The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein |
Q41381054 | The human foamy virus internal promoter is required for efficient gene expression and infectivity |
Q42461791 | Transcription factor AP1 modulates the internal promoter activity of bovine foamy virus |
Q36627085 | Transcriptional mapping of the 3' end of the bovine syncytial virus genome. |
Q40348017 | Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release |
Q50768690 | [Comparison of several viral vectors for gene therapy of corneal endothelial cells]. |
Search more.